Literature DB >> 30118141

Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?

Yi Ji1, Siyuan Chen2, Kaiying Yang1, Chunchao Xia3, Suhua Peng1.   

Abstract

Kasabach-Merritt phenomenon (KMP) occurred uniquely in patients with kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). We report the clinical characteristics of two patients with KHE involving the right upper arm. The patients demonstrated rapid enlargement of the lesion with severe KMP shortly after vaccination. Sirolimus was used to treat the KHE with KMP. The patients showed a quick normalization of the platelet level. The follow-up examination revealed that the size of the mass was significantly decreased. This report raises the intriguing possibility that extrinsic factors may contribute to the development of KMP in the context of an already existing KHE.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  Kasabach-Merritt phenomenon; kaposiform hemangioendothelioma; platelet level; sirolimus; vaccination

Mesh:

Substances:

Year:  2018        PMID: 30118141     DOI: 10.1111/1346-8138.14598

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  Aggressive vascular tumor mimicking posttraumatic hematoma: A case report of kaposiform hemangioendothelioma on the nose.

Authors:  Floris V W J van Zijl; Peter C J de Laat; Robert M Verdijk; Andries P Nagtegaal; Frank R Datema
Journal:  JAAD Case Rep       Date:  2022-06-09

Review 2.  Repurposing Infectious Diseases Vaccines Against Cancer.

Authors:  Liese Vandeborne; Pan Pantziarka; An M T Van Nuffel; Gauthier Bouche
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 3.  Kaposiform hemangioendothelioma: current knowledge and future perspectives.

Authors:  Yi Ji; Siyuan Chen; Kaiying Yang; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

4.  Comparison of Effectiveness of Two Different Doses of Propranolol on Kaposiform Hemangioendothelioma.

Authors:  Li Wei; Li Li; Zigang Xu; Bin Zhang; Xiaofeng Han; Chen Wang; Yuanxiang Liu; Bingyu Xiu; Lei Qiu; Yujuan Sun; Lin Ma
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

5.  Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.

Authors:  Veroniek E M Harbers; Nathalie van der Salm; Sjoert A H Pegge; Carine J M van der Vleuten; Bas H Verhoeven; Sabine L A G Vrancken; Leo J Schultze Kool; Joris Fuijkschot; D Maroeska M W M Te Loo
Journal:  Br J Clin Pharmacol       Date:  2022-01-18       Impact factor: 3.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.